Kuros Biosciences AG (KURN.SW) SIX
20.70
+1.7(+8.95%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.06B |
| Enterprise Value | 1.04B |
| P/E Ratio | 495.09 |
| PEG Ratio | 9.69 |
| Price/Sales Ratio | 6.27 |
| Price/Book Ratio | 12.11 |
| Enterprise/Revenue | 6.18 |
| Enterprise/EBITDA | 78.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.06 |
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 121.3M |
| Revenue/Share | 3.31 |
| Gross Profit | 104.79M |
| EBITDA | 10.13M |
| Net Income | 2.12M |
| Diluted EPS | 0.05 |
Balance Sheet
| Total Cash | 15.66M |
| Total Cash/Share | 0.4 |
| Total Debt | 3.94M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 1.96 |
| Book Value Per Share | 1.71 |
Price History
| 52-Week Change | -14.11 |
| 52-Week High | 34.2 |
| 52-Week Low | 18.7 |
| Moving Average 50 Days | 23.33 |
| Moving Average 200 Days | 26.3 |
Statistics
| Average Volume | 192,069 |
| Shares Outstanding | 39.25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 217:200 |
| Last Split Date | October 08, 2020 |
